FNDC5 and Obesity: If, from one side, irisin reduction might lead to some metabolic changes involved in the onset and progression of a disease, on the other side its up-regulation could be a consequence of an “irisin resistance” state and therefore an attempt to maximize the anti-obesity, anti-hyperglycemic and healthy effects of the molecule.